CII
IDXX icon

CR Intrinsic Investors’s Idexx Laboratories IDXX Stock Holding History

CR Intrinsic Investors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-180,000
Closed -$10.9M – 95
2014
Q1 		$10.9M Buy
+180,000
New +$10.7M 0.41% 87

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

CR Intrinsic Investors's IDXX Position: Q2 2014 in Review

CR Intrinsic Investors sold out of Idexx Laboratories (IDXX) in Q2 2014, closing a stake of 180,000 shares — an estimated $10.9M sold.

CR Intrinsic Investors first reported a position in IDXX in Q1 2014 and held it in 1 quarter. The position peaked at $10.9M in Q1 2014. 306 funds tracked by Wall St. Rank hold IDXX as of Q2 2014.

  • CR Intrinsic Investors reported no remaining Idexx Laboratories position as of Q2 2014 after selling out during the quarter.
  • CR Intrinsic Investors sold 180,000 Idexx Laboratories shares in Q2 2014, an estimated $10.9M.
  • CR Intrinsic Investors first reported a position in Idexx Laboratories in Q1 2014 and held it in 1 quarter.
  • CR Intrinsic Investors's Idexx Laboratories position peaked at $10.9M in Q1 2014.
  • 306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.